Cargando…
Using subjective cognitive decline to identify high global amyloid in community-based samples: A cross-cohort study
INTRODUCTION: We aimed to examine the contribution of subjective cognitive decline (SCD) to reduce the number of β-amyloid (Aβ) positron emission tomography scans required for recruiting Aβ+ clinically normal individuals in clinical trials. METHODS: Three independent cohorts (890 clinically normal:...
Autores principales: | Buckley, Rachel F., Sikkes, Sietske, Villemagne, Victor L., Mormino, Elizabeth C., Rabin, Jennifer S., Burnham, Samantha, Papp, Kathryn V., Doré, Vincent, Masters, Colin L., Properzi, Michael J., Schultz, Aaron P., Johnson, Keith A., Rentz, Dorene M., Sperling, Reisa A., Amariglio, Rebecca E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816447/ https://www.ncbi.nlm.nih.gov/pubmed/31673597 http://dx.doi.org/10.1016/j.dadm.2019.08.004 |
Ejemplares similares
-
Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021) -
Instrumental activities of daily living, amyloid, and cognition in cognitively normal older adults screening for the A4 Study
por: Marshall, Gad A., et al.
Publicado: (2020) -
Neuroimaging correlates of Stages of Objective Memory Impairment (SOMI) system
por: Grober, Ellen, et al.
Publicado: (2021) -
The relationship between recall of recently versus remotely encoded famous faces and amyloidosis in clinically normal older adults
por: Orlovsky, Irina, et al.
Publicado: (2017) -
Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)